The feeder-independent human embryonic stem cell (hESC) line, WA09, was obtained from the WiCell mTeSR™1 Bank and cultivated in either mTeSR™1 (Stem Cell Technologies, 05850) or adapted to StemPro® hESC SFM (Life Technologies, A1000701). Cell stocks were continuously maintained in feeder-independent conditions on hESC-Qualified Matrigel™ (Becton Dickinson, 354277) in a humidified, 37°C cell incubator equilibrated with 5% CO2. Later, an additional feeder-independent hESC line, WA07 (WiCell mTeSR™1 Bank) and two human induced pluripotent stem cell (hiPSC) lines, hiPSC18R and hiPSC19K (Lonza–Walkersville), were also cultivated continuously in the hypertonic citrate solution to determine if additional hPSC lines could also maintain their pluripotency. Both hiPSC lines were generated from human cord blood CD34+ cells.
Free full text: Click here